Dr. Pride Chigwedere, an affiliate of the Harvard AIDS Initiative, speaks with host Dr. Cathleen Margolin about the role of government policy in the AIDS epidemic in South Africa. Dr. Chigwedere's research, as published in the Journal of Acquired Immune Deficiency Syndromes, pins fault on these frightening government rules for the loss of more than 3.8 million person-years in the early portion of this decade. How is South Africa now moving toward a state of accountability for this crucial aspect of their overall public health strategy?
The Human Toll of South Africa's Early AIDS Policies

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Pride Chigwedere, an affiliate of the Harvard AIDS Initiative, speaks with host Dr. Cathleen Margolin about the role of government policy in the AIDS epidemic in South Africa. Dr. Chigwedere's research, as published in the Journal of Acquired Immune Deficiency Syndromes, pins fault on these frightening government rules for the loss of more than 3.8 million person-years in the early portion of this decade. How is South Africa now moving toward a state of accountability for this crucial aspect of their overall public health strategy?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Partnering with Patients: Building Effective Communication and Support in HF Care
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?